The pharmaceutical industry is a key component in the health and well-being of the general populace, and many organizations in the sector have grown to the point where they’re able to give partial ownership to the individuals they serve. Publicly traded companies enable free trading of their shares of stock on exchanges, like the NYSE or Nasdaq, or through over-the-counter markets, which offer access to securities that are not listed on a national securities exchange.
These companies are also constantly under close scrutiny since they are required to regularly disclose their financial and business information publicly to their shareholders. For pharmaceutical corporations, which are already thoroughly examined for the safety and efficacy of their therapeutic products, trading stocks publicly is a sign of financial confidence, business success and overall growth.
Organizations that have achieved the milestone of completing an initial public offering typically have a large pool of career opportunities and offer structured growth opportunities for their employees. Additionally, skilled talent will always be in demand within health and medicine. Read the list below for more details about publicly traded companies in the pharmaceutical industry.
Publicly Traded Pharmaceutical Companies
Cencora
Pfizer
Eli Lilly and Company
Johnson & Johnson
AbbVie
AstraZeneca
Vertex Pharmaceuticals
Regeneron
Jazz Pharmaceuticals
BioMarin
Publicly Traded Pharmaceutical Companies
Exchange: NYSE
Stock Symbol: AZN
AstraZeneca is a global, science-led pharmaceutical business dedicated to research, development and commercialization for prescription medicines. The company works to ensure better outcomes for patients, helping improve their quality of life. Its therapy focuses include oncology, cardiovascular, renal and metabolism, respiratory and immunology and rare and infectious diseases.
Exchange: NYSE
Stock Symbol: ABBV
AbbVie develops medicines and other solutions to make a positive impact on patients, communities and the world. The company’s focus spans specialties like immunology, oncology, neuroscience, eye care and aesthetics. It prioritizes innovation in areas ranging from genomics to precision medicine.
Exchange: NASDAQ
Stock Symbol: VRTX
Vertex Pharmaceuticals develops medicines for patients with serious diseases, such as sickle cell disease, kidney diseases, type 1 diabetes, cystic fibrosis and beta thalassemia. The company invests heavily in science to change lives and discover cures, and it operates R&D sites and commercial offices across the globe.
Exchange: NASDAQ
Stock Symbol: JAZZ
Jazz Pharmaceuticals works to help people with rare diseases live their lives more fully. It turns biopharmaceutical discoveries into novel medicines and has a diverse array of medicines on the market. Its products treat rare epilepsies, cancers and sleep disorders. Jazz applies a science-driven approach to fueling R&D across its therapeutic pipeline.
Exchange: NASDAQ
Stock Symbol: REGN
Regeneron leverages science to develop and commercialize life-transforming medicines for people with serious diseases. It has dozens of therapeutic candidates in development, and several of its medicines developed in-house have been approved. Regeneron helps patients with eye diseases, allergic and inflammatory diseases, neurological diseases, hematologic conditions and other conditions.
Exchange: NYSE
Stock Symbol: LLY
Eli Lilly and Company operates as a medicine company that helps patients find care, access pharmacies and join clinical trials. It also provides support for individuals with conditions in areas like cancer, dermatology, autoimmune disease, diabetes and more. In addition to developing medicines, Eli Lilly and Company provides home delivery for its original medicines.
Exchange: NASDAQ
Stock Symbol: BMRN
BioMarin is a global rare disease biotech company that delivers medicines for people living with genetically defined conditions. It has nine commercial therapies on the market for treating metabolic and skeletal conditions. BioMarin’s team specializes in genomics and medicine, leveraging their expertise to translate genetic discoveries into transformative medicines.
Exchange: NYSE
Stock Symbol: JNJ
Johnson & Johnson Innovative Medicine, the pharmaceutical business segment of multinational healthcare enterprise Johnson & Johnson, develops treatments to change and save lives. It works to address complex diseases in fields including oncology, immunology, neuroscience and cardiopulmonary. Meanwhile, Johnson & Johnson MedTech combines biology and technology expertise to enable precision treatments for the cardiovascular, orthopedics, surgery and vision areas of healthcare.
Exchange: NYSE
Stock Symbol: PFE
Pfizer’s goal is to achieve breakthroughs that change patients’ lives. The company partners with healthcare systems to increase access to its medicines and leverages digital technology to enhance drug discovery and development. Pfizer’s R&D branch focuses on internal medicine, oncology, vaccines and inflammation and immunology.
Exchange: NYSE
Stock Symbol: COR
Cencora aims to improve the lives of people and animals with pharmaceutical solutions designed to facilitate more efficient healthcare delivery and yield better health outcomes. The company serves manufacturers and providers through tools that support scalability and capabilities that help them achieve commercial success and accelerate growth.
